Search - tctmd.com

Displaying 181 - 200 of 496

Sort: Relevancy | Date

New CV Risk Model Predicts Recurrent MACE at 1 Year in Post-MI Patients

News Daily News

New CV Risk Model Predicts Recurrent MACE at 1 Year in Post-MI Patients

Michael O'Riordan

August 13, 2018

ESC Algorithm Safely Rules Out NSTEMI, but Caution May Be Warranted in the US

News Daily News

ESC Algorithm Safely Rules Out NSTEMI, but Caution May Be Warranted in the US

August 01, 2018

SCAI Updates Statement on Intracoronary Diagnostic Tools

News Daily News

SCAI Updates Statement on Intracoronary Diagnostic Tools

July 17, 2018

OCT, IVUS Each Boost Long-term Outcomes When Used to Guide PCI, Study Suggests

News Daily News

OCT, IVUS Each Boost Long-term Outcomes When Used to Guide PCI, Study Suggests

July 16, 2018

SGLT2 Inhibitors Work in Type 2 Diabetes Across Levels of CV Risk, Renal Function

News Daily News

SGLT2 Inhibitors Work in Type 2 Diabetes Across Levels of CV Risk, Renal Function

July 02, 2018

The M Word: Is Routine Transfemoral PCI Defensible in 2018?

News Features

The M Word: Is Routine Transfemoral PCI Defensible in 2018?

June 08, 2018

Shortfalls in MI Care Hit Lowest Socioeconomic Groups the Hardest

News Daily News

Shortfalls in MI Care Hit Lowest Socioeconomic Groups the Hardest

June 06, 2018

One in Five ACS Patients Does Not Fill P2Y12 Inhibitor Prescription After PCI

News Daily News

One in Five ACS Patients Does Not Fill P2Y12 Inhibitor Prescription After PCI

Michael O'Riordan

May 21, 2018

Less Bleeding, Similar Outcomes With Dual vs Triple Therapy After PCI in Patients With A-fib

News Daily News

Less Bleeding, Similar Outcomes With Dual vs Triple Therapy After PCI in Patients With A-fib

April 24, 2018

Silent MI Often Precedes Acute MI, Portends Worse Patient Outcomes

News Daily News

Silent MI Often Precedes Acute MI, Portends Worse Patient Outcomes

April 18, 2018

No Link Between Operator Volume and Post-PCI Mortality in the UK

News Daily News

No Link Between Operator Volume and Post-PCI Mortality in the UK

March 27, 2018

Varenicline Boosts Long-term Quit Rate in Post-ACS Smokers: EVITA

News Daily News

Varenicline Boosts Long-term Quit Rate in Post-ACS Smokers: EVITA

March 26, 2018

ACC 2018, Day Three: Gout, Hypertension, and Diabetes Dominate Opening Late Breaker

News Conference News ACC 2018

ACC 2018, Day Three: Gout, Hypertension, Diabetes, PFO Closure, DAPT, NOAC Reversal, and More

March 12, 2018

SECURE-PCI Comes Up Short for Statin Preloading in ACS Patients

News Conference News ACC 2018

SECURE-PCI Comes Up Short for Statin Preloading in ACS Patients

Michael O'Riordan

March 11, 2018

TREAT: No Major Bleeds With Ticagrelor in ACS Patients After Fibrinolysis

News Conference News ACC 2018

TREAT: No Major Bleeds With Ticagrelor in ACS Patients After Fibrinolysis

March 11, 2018

Reducing Co-payments for P2Y12 Inhibitors Upped Ticagrelor Use but Didn’t Budge MACE: ARTEMIS

News Conference News ACC 2018

Reducing Co-payments for P2Y12 Inhibitors Upped Ticagrelor Use but Didn’t Budge MACE: ARTEMIS

March 11, 2018

ACC 2018, Day Two: Antiplatelets in ACS, Dabigatran in Noncardiac Surgery, and More

News Conference News ACC 2018

ACC 2018, Day Two: Antiplatelets in ACS, Dabigatran in Noncardiac Surgery, and More

March 11, 2018

Routine Use of FFR, iFR Changes Treatment Plans, Even in Patients With Multivessel Disease

News Daily News

Routine Use of FFR, iFR Changes Treatment Plans, Even in Patients With Multivessel Disease

February 21, 2018

Acute MI Quality Improvement Program Fails in India, but Researchers See Bright Side

News Daily News

Acute MI Quality Improvement Program Fails in India, but Researchers See Bright Side

February 15, 2018

Risk Scores Combined With Lower Troponin Cut Points May Help Refine Rule-Out Tests for Chest Pain

News Daily News

Risk Scores Combined With Lower Troponin Cut Points May Help Refine Rule-Out Tests for Chest Pain

February 05, 2018

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.